Cilengitide is a cyclic oligopeptide composed of the amino acid sequence arginine-glycine-aspartic acid-D-phenylalanine-N-methylvaline. It has been studied in clinical trials for its potential role in cancer research.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 188968-51-6
Cyclo(Arg-Gly-Asp-D-Phe-Val)
pharmaceutical raw material
Cyclo(RGDfC)
research compound
3-aminopiperidine-2-one
human metabolite
9-Benzyl-3,9-diazaspiro[5.5]undecane-2,4-dione
pharmaceutical intermediate
(3R,4S)-3-FLUOROOXAN-4-OL
Research compound
1-(2-bromophenyl)naphthalene
research compound
Cyclic RGDFK peptide
research compound
2-[(2S,5R,8S,11S)-5-benzyl-11-[3-(diaminomethylideneamino)propyl]-7-methyl-3,6,9,12,15-pentaoxo-8-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid
AMLYAMJWYAIXIA-VWNVYAMZSA-N
CC(C)[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C(=O)N1C)CC2=CC=CC=C2)CC(=O)O)CCCN=C(N)N